CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
CD40L-expressing chimeric antigen receptor (CAR) T cells show enhanced anti-tumor immunity, but the cellular mechanisms are still unclear. Here we show, by analyzing mice deficient of conventional dendritic cell type 1 (cDC1) that cDC1s are induced by CD40L+ CAR T cells to prime endogenous CD8 T cel...
Saved in:
Main Authors: | Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li, Winson Cai, Anthony F. Daniyan, Renier J. Brentjens |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/73e25f98128942e1a7488cf2c4e6a8e9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
by: Thomas Duhen, et al.
Published: (2018) -
TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine
by: C. C. Bain, et al.
Published: (2017) -
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
by: Leonardo M. R. Ferreira, et al.
Published: (2021) -
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis
by: Christian Barthels, et al.
Published: (2017) -
Erratum: CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis
by: Christian Barthels, et al.
Published: (2017)